Oct 23 (Reuters) - Correvio Pharma Corp CORV.TO :
* CORREVIO ANNOUNCES INTENTION TO RE-FILE BRINAVESS NDA IN SECOND QUARTER 2019
* CORREVIO PHARMA CORP - PLANS TO RESUBMIT BRINAVESS (VERNAKALANT HYDROCHLORIDE, IV) NEW DRUG APPLICATION (NDA) DURING Q2 OF 2019
* CORREVIO PHARMA CORP - NO ADDITIONAL STUDIES REQUIRED FOR RESUBMISSION